These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15283807)

  • 1. Re: Candida albicans: an immune response modifier.
    Signore RJ
    Pediatr Dermatol; 2004; 21(4):512. PubMed ID: 15283807
    [No Abstract]   [Full Text] [Related]  

  • 2. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy.
    Johnson SM; Horn TD
    J Drugs Dermatol; 2004; 3(3):263-5. PubMed ID: 15176159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interstrain differences in mice in developing migration inhibition factors to Candida albicans antigens].
    Vorob'ev KV; Gankovskaia LV; Koval'chuk LV; Shabanova LF
    Biull Eksp Biol Med; 1983 Oct; 96(10):80-2. PubMed ID: 6354302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The adjuvant and specific activity of transfer factors to Candida albicans antigens].
    Borysov VA; Cheusova ZV; Molozhava OS
    Fiziol Zh (1994); 1998; 44(4):3-9. PubMed ID: 9669168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic variability of Candida albicans cell surface.
    Cutler JE; Kanbe T
    Curr Top Med Mycol; 1993; 5():27-47. PubMed ID: 8242804
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunochemical properties of soluble fractions of Candida albicans.
    Alonso A; Scavini LM; Pionetti CH; Mouchian K; Rodríguez S
    Medicina (B Aires); 1981; 41(5):579-86. PubMed ID: 7047975
    [No Abstract]   [Full Text] [Related]  

  • 7. Candida and allergy.
    Palma-Carlos AG; Palma-Carlos ML; Costa AC
    Allerg Immunol (Paris); 2002 Nov; 34(9):322-4. PubMed ID: 12512190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development and evaluation of a new Candida albicans antigen].
    Herrmann K; Rademacher KH
    Dermatol Monatsschr; 1983; 169(7):440-5. PubMed ID: 6414853
    [No Abstract]   [Full Text] [Related]  

  • 9. The status of immunotherapy in the United States, 2002.
    Silverberg NB
    Cutis; 2002 Sep; 70(3):155-6. PubMed ID: 12353888
    [No Abstract]   [Full Text] [Related]  

  • 10. Candida albicans intralesional injection immunotherapy of warts.
    Signore RJ
    Cutis; 2002 Sep; 70(3):185-92. PubMed ID: 12353895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of interferon gamma in the prediction of successful therapy of common warts by intralesional injection of Candida antigen.
    Nofal A; Marei A; Amer A; Amen H
    Int J Dermatol; 2017 Oct; 56(10):1003-1009. PubMed ID: 28791682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alarming complication of Candida albicans antigen treatment of recalcitrant warts.
    Signore RJ
    Dermatitis; 2005 Dec; 16(4):216; author reply 216-7. PubMed ID: 16536337
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined acitretin and Candida antigen versus either agent alone in the treatment of recalcitrant warts.
    Nofal A; Khattab F; Nofal E; Elgohary A
    J Am Acad Dermatol; 2018 Aug; 79(2):377-378. PubMed ID: 29339242
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical studies on asthmatic children induced by Candida antigen].
    Kondo H; Tsuruta M; Hayakawa Y; Nakahara T; Tsuda K; Miyata T; Yazaki T; Hida Y; Urisu A; Torii S
    Arerugi; 1984 Jul; 33(7):381-8. PubMed ID: 6388530
    [No Abstract]   [Full Text] [Related]  

  • 15. Release of surface antigens of Candida albicans after treatment with pyrrolnitrin.
    Misefari A; Costa G; Costa AL; Valenti A
    Farmaco Prat; 1979 Jan; 34(1):42-5. PubMed ID: 378688
    [No Abstract]   [Full Text] [Related]  

  • 16. Defect internalization and tyrosine kinase activation in Aire deficient antigen presenting cells exposed to Candida albicans antigens.
    Brännström J; Hässler S; Peltonen L; Herrmann B; Winqvist O
    Clin Immunol; 2006 Dec; 121(3):265-73. PubMed ID: 16982213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic reactions with Candida albicans].
    Seeliger HP; Tomsikova A; Török I
    Mykosen; 1975 Apr; 18(4):149-60. PubMed ID: 1102971
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fungal allergy].
    Takahashi T
    Nihon Rinsho; 1980 Nov; 38(11):4295-300. PubMed ID: 7019484
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic indices following intranasal and aerosol sensitization to Candida albicans antigen].
    Sardyko NV
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):112-3. PubMed ID: 7036600
    [No Abstract]   [Full Text] [Related]  

  • 20. [Agglutination of Candida albicans cells following the extraction of soluble antigens with 3M KCl and autoclaving].
    Marconi P; Bistoni F; Boncio L; Bravi P; Pitzurra M
    Boll Soc Ital Biol Sper; 1975 Oct; 51(20):1436-9. PubMed ID: 782487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.